N⁴-[3-(1H-imidazol-1-yl)propyl]-2-methyl-1,4-benzenediamine | 329943-31-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N⁴-[3-(1H-imidazol-1-yl)propyl]-2-methyl-1,4-benzenediamine
• 英文别名: n-(4-Amino-3-methylphenyl)-n-[3-(1h-imidazol-1-yl)propyl]amine；4-N-(3-imidazol-1-ylpropyl)-2-methylbenzene-1,4-diamine
• CAS: 329943-31-9
• 化学式: C₁₃H₁₈N₄
• mdl: MFCD12410450
• 分子量: 230.313
• InChiKey: CDUWBJWAFZKYOF-UHFFFAOYSA-N

物化性质

• 沸点：
  491.7±35.0 °C(Predicted)
• 密度：
  1.14±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  17
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.307
• 拓扑面积：
  55.9
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  N⁴-[3-(1H-imidazol-1-yl)propyl]-2-methyl-1,4-benzenediamine 、 [4-chloro-2-(3,5-difluorobenzoyl)phenoxy]acetyl chloride 在 碳酸氢钠 作用下， 以 丙酮 为溶剂， 反应 2.5h， 以0.219 g的产率得到2-[4-chloro-2-(3,5-difluorobenzoyl)phenoxy]-N-[4-(3-imidazol-1-ylpropylamino)-2-methyl-phenyl]acetamide
  参考文献：
  名称：

  Structure−Activity Relationship Studies of Novel Benzophenones Leading to the Discovery of a Potent, Next Generation HIV Nonnucleoside Reverse Transcriptase Inhibitor

  摘要：

  Despite the progress of the past two decades, there is still considerable need for safe, efficacious drugs that target human immunodeficiency virus (HIV). This is particularly true for the growing number of patients infected with virus resistant to currently approved HIV drugs. Our high throughput screening effort identified a benzophenone template as a potential nonnucleoside reverse transcriptase inhibitor (NNRTI). This manuscript describes our extensive exploration of the benzophenone structure-activity relationships, which culminated in the identification of several compounds with very potent inhibition of both wild type and clinically relevant NNRTI-resistant mutant strains of HIV. These potent inhibitors include 70h (GW678248), which has in vitro antiviral assay IC50 values of 0.5 nM against wild-type HIV, 1 nM against the K103N mutant associated with clinical resistance to efavirenz, and 0.7 nM against the Y181C mutant associated with clinical resistance to nevirapine. Compound 70h has also demonstrated relatively low clearance in intravenous pharmacokinetic studies in three species, and it is the active component of a drug candidate which has progressed to phase 2 clinical studies.

  DOI：

  10.1021/jm050670l
• 作为产物：
  描述：

  1-(3-氨基丙基)咪唑 在 palladium on activated charcoal 吡啶 、 氢气 、 碳酸氢钠 作用下， 以 甲醇 为溶剂， 20.0 ℃ 、358.53 kPa 条件下， 反应 4.0h， 生成 N⁴-[3-(1H-imidazol-1-yl)propyl]-2-methyl-1,4-benzenediamine
  参考文献：
  名称：

  Structure−Activity Relationship Studies of Novel Benzophenones Leading to the Discovery of a Potent, Next Generation HIV Nonnucleoside Reverse Transcriptase Inhibitor

  摘要：

  Despite the progress of the past two decades, there is still considerable need for safe, efficacious drugs that target human immunodeficiency virus (HIV). This is particularly true for the growing number of patients infected with virus resistant to currently approved HIV drugs. Our high throughput screening effort identified a benzophenone template as a potential nonnucleoside reverse transcriptase inhibitor (NNRTI). This manuscript describes our extensive exploration of the benzophenone structure-activity relationships, which culminated in the identification of several compounds with very potent inhibition of both wild type and clinically relevant NNRTI-resistant mutant strains of HIV. These potent inhibitors include 70h (GW678248), which has in vitro antiviral assay IC50 values of 0.5 nM against wild-type HIV, 1 nM against the K103N mutant associated with clinical resistance to efavirenz, and 0.7 nM against the Y181C mutant associated with clinical resistance to nevirapine. Compound 70h has also demonstrated relatively low clearance in intravenous pharmacokinetic studies in three species, and it is the active component of a drug candidate which has progressed to phase 2 clinical studies.

  DOI：

  10.1021/jm050670l

文献信息

• [EN] DYE COMPOSITION COMPRISING A CATIONIC O-ALKYL-SUBSTITUTED META-PHENYLENEDIAMINE DERIVATIVE<br/>[FR] COMPOSITION DE TEINTURE COMPRENANT UN DÉRIVÉ DE MÉTA-PHÉNYLÈNEDIAMINE CATIONIQUE À SUBSTITUTION ALKYLE O
  申请人：OREAL

  公开号：WO2014026952A1

  公开（公告）日：2014-02-20

  The invention relates to a meta-phenylenediamine compound of formula (I) below, the addition salts thereof with an acid and the solvates thereof: in which: R represents a hydrogen or halogen atom; a C1-C4 alkyl radical; a carboxyl radical or a (C1-C4) alkoxycarbonyl radical, R1 represents a linear C1-C10 alkyl radical substituted with a cationic radical, said alkyl radical being optionally interrupted with one or more oxygen atoms and/or with one or more NR6 groups, said cationic radical being optionally substituted with one or more radicals chosen from C1-C4 alkoxy or C1-C4 (hydroxy )alkyl; R6 represents a hydrogen atom or a linear or branched C1-C4 alkyl radical; An- represents an anion or a mixture of anions which are organic or inorganic and cosmetically acceptable.

  该发明涉及以下式（I）的一个甲苯二胺类化合物，以及其与酸的加合盐和溶剂化合物：其中：R代表氢或卤素原子；一个C1-C4烷基基团；一个羧基或（C1-C4）烷氧羰基基团，R1代表一个线性的C1-C10烷基基团，该基团被一个阳离子基团取代，所述烷基基团可以选择性地被一个或多个氧原子和/或一个或多个NR6基团中断，所述阳离子基团可以选择性地被一个或多个从C1-C4烷氧基或C1-C4（羟基）烷基中选择的基团取代；R6代表氢原子或线性或支链的C1-C4烷基基团；An-代表一个有机或无机且在化妆品中可接受的阴离子或阴离子混合物。
• HAIR DYE AGENT COMPRISING AMINOPYRIMIDINE DERIVATIVES
  申请人：Henkel AG & Co. KGaA

  公开号：US20150209258A1

  公开（公告）日：2015-07-30

  The present application relates to agents for dyeing keratin fibers, in particular human hair, the agent including a cosmetic carrier and at least a compound of formula (I)

  本申请涉及染色角蛋白纤维的药剂，特别是人类头发，该药剂包括化妆品载体和至少一种符合式(I)的化合物。
• SUBSTITUTED P-PHENYLENEDIAMINES AS NEW OXIDATION DYE PRECURSOR PRODUCTS OF THE DEVELOPER TYPE
  申请人：Henkel AG & Co. KGaA

  公开号：US20170165166A1

  公开（公告）日：2017-06-15

  Compounds, and agents for oxidatively changing the color of keratinic fibers that include such compounds, in particular human hair, in a cosmetic carrier. The compounds are at least one oxidation dye precursor product of formula (I) and/or physiologically acceptable salt thereof, in which R1, R2, R3, R4 independently of one another, stand for a hydrogen atom, a C 1 -C 6 alkyl group, a C 2 -C 6 alkenyl group, a hydroxy-(C 1 -C 6 )-alkyl group, a polyhydroxy-(C 2 -C 6 )-alkyl group, or a C 1 -C 6 -alkoxy-C 2 -C 6 -alkyl group, n stands for an integer from 2 to 6, and Z stands for an aromatic or aliphatic heterocycle or for an aromatic or aliphatic carbocycle.

  这段文字的中文翻译如下： 化合物和氧化性改变角蛋白纤维颜色的药剂，包括这些化合物，特别是人类头发，在化妆品载体中。这些化合物至少是一种化学式(I)的氧化染料前体产品和/或其生理上可接受的盐，其中R1、R2、R3、R4分别独立地代表氢原子、C1-C6烷基、C2-C6烯基、羟基-(C1-C6)-烷基、多羟基-(C2-C6)-烷基或C1-C6-烷氧基-C2-C6-烷基，n代表一个从2到6的整数，Z代表芳香或脂肪杂环或芳香或脂肪碳环。
• AGENT FOR DYEING KERATIN-CONTAINING FIBERS
  申请人：Gross Wibke

  公开号：US20100064450A1

  公开（公告）日：2010-03-18

  The invention relates to an agent for dying fibers comprising keratin, particularly human hair, the agent comprising at least one compound of the formula: together with at least one CH-acidic compound. The invention also relates to methods for shading oxidation dyed fibers, methods for freshening up fibers, methods for making an agent for dyeing fibers and to various compositions.

  该发明涉及一种用于染色纤维的药剂，包括角蛋白，特别是人类头发，该药剂包括至少一种具有以下结构的化合物：以及至少一种CH-酸性化合物。该发明还涉及用于给氧化染色纤维着色的方法，用于使纤维焕发的方法，用于制备染色纤维药剂的方法以及各种组合物。
• GLUCURONOLACTONE DERIVATIVES AS SELF-TANNING SUBSTANCES
  申请人：MERCK PATENT GMBH

  公开号：US20150098914A1

  公开（公告）日：2015-04-09

  The invention relates to the use of specific glucuronolactone derivatives as self-tanning substances, as tanning enhancers for dihydroxyacetone or for a mixture of self-tanning substances comprising dihydroxyacetone, for modulation of the colour shade achieved in the case of tanning with dihydroxyacetone or by the mixture or preparation comprising dihydroxyacetone, as contrast-reduction agents or for colouring keratin-containing fibres, and to preparations or compositions for colouring keratin-containing fibres comprising these specific glucuronolactone derivatives.

  该发明涉及将特定的葡萄糖醛内酯衍生物用作自我晒黑物质，用作增强二羟基丙酮的晒黑效果，或用于包含二羟基丙酮的自我晒黑物质混合物的调节，以调节使用二羟基丙酮或包含二羟基丙酮的混合物或制剂晒黑时所达到的颜色深浅，作为降低对比度的剂或用于给含角蛋白的纤维着色，以及用于含角蛋白纤维着色的制剂或组合物，其中包括这些特定的葡萄糖醛内酯衍生物。